1Globe Health Institute

1Globe Health Institute (GHI), a unique research organization with an entrepreneurial culture characterized by a hybrid of academia and industry, is dedicated to fundamental biotechnology innovation based upon its proprietary technology platforms, including the award-winning asymmetrical gene-silencing technology (aiRNA), novel nanotechnology, and synthetic biology. At GHI, we are passionate about using innovative ideas and cutting-edge technology to combat hard-to-treat diseases. We are a growing company, created and operated by scientists who perform focused research to develop novel therapeutics along an accelerated timeline. Our team consists of a diverse and driven group of scientists and clinicians experienced in research and discovery, product development, finance, and clinical affairs.